Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat
Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg...
Gespeichert in:
Veröffentlicht in: | Nephrology, dialysis, transplantation dialysis, transplantation, 2003-11, Vol.18 (11), p.2269-2277 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2277 |
---|---|
container_issue | 11 |
container_start_page | 2269 |
container_title | Nephrology, dialysis, transplantation |
container_volume | 18 |
creator | Lindström, Pernilla Wadström, Jonas Ollerstam, Anna Johnsson, Cecilia Persson, A. Erik G. |
description | Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg by insufflation of CO2 and maintained for 2 h in anaesthetized and mechanically ventilated rats. Rats with normal IAP served as controls. An angiotensin II receptor I antagonist, candesartan, was given as a bolus injection and a 5% volume expansion was achieved by i.v. saline infusion. An angiotensin-converting enzyme (ACE) inhibitor was also given. Renal parameters were the glomerular filtration rate (GFR), urine production, the urinary concentrations of sodium and potassium and the osmolality in the urine. The arterial acid–base balance and blood pressure were also monitored. Results. The GFR deteriorated by 70% during pneumoperitoneum (PP) of 10 mmHg. There was a dramatic drop in sodium excretion (88–97%). With candesartan and elevated IAP, there was a drop in mean arterial pressure (from 90 to 55 mmHg) and the negative renal effects were very pronounced. Renal function was better preserved during elevated IAP in combination with volume expansion. Conclusions. Capnoperitoneum suppresses renal function, especially in combination with angiotensin II receptor 1 blockade and ACE inhibition. Volume expansion reduces the deleterious effects of PP on renal function during elevated IAP. The results suggest that patients should not be given pharmaceuticals blocking the renin–angiotensin–aldosterone system prior to procedures that may increase IAP. It may be beneficial, however, to reduce angiotensin II tension by volume expansion. |
doi_str_mv | 10.1093/ndt/gfg362 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75757528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75757528</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-6f98190c7d4fba63c7e844487212f33a30eab4710184c066555ec3f39ed8ecb53</originalsourceid><addsrcrecordid>eNpF0M9rFTEQB_BQlPZZe-kfUHLRg7A2v7N71FJbpSCI0tJLmM1O6upu9plkpf733eU9LBnIMPNhDl9CTjl7z1kjz2NXzh_CgzTigGy4MqwSstYvyGZZ8opp1hyRVzn_Yow1wtpDcsSV1lxquSHuMgT0JdMp0D76hJCxW7qSoIK2m8Y-wkC3CXOeE1KIHf07DfOIFB-3EHM_RbpUwpWFOfqyTvpIy0-kCcpr8jLAkPFk_x-TH58uv19cVzdfrz5ffLipvKxtqUxoat4wbzsVWjDSW6yVUrUVXAQpQTKEVlnOeK08M0ZrjV4G2WBXo2-1PCZvd3e3afozYy5u7LPHYYCI05yd1esT9QLf7aBPU84Jg9umfoT0z3Hm1jjdEqfbxbngs_3VuR2xe6b7_BbwZg8gexhCguj7_Oy04I2Vq6t2rs8FH__vIf12xkqr3fXdvftohPhivil3K58AnmqNvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75757528</pqid></control><display><type>article</type><title>Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Lindström, Pernilla ; Wadström, Jonas ; Ollerstam, Anna ; Johnsson, Cecilia ; Persson, A. Erik G.</creator><creatorcontrib>Lindström, Pernilla ; Wadström, Jonas ; Ollerstam, Anna ; Johnsson, Cecilia ; Persson, A. Erik G.</creatorcontrib><description>Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg by insufflation of CO2 and maintained for 2 h in anaesthetized and mechanically ventilated rats. Rats with normal IAP served as controls. An angiotensin II receptor I antagonist, candesartan, was given as a bolus injection and a 5% volume expansion was achieved by i.v. saline infusion. An angiotensin-converting enzyme (ACE) inhibitor was also given. Renal parameters were the glomerular filtration rate (GFR), urine production, the urinary concentrations of sodium and potassium and the osmolality in the urine. The arterial acid–base balance and blood pressure were also monitored. Results. The GFR deteriorated by 70% during pneumoperitoneum (PP) of 10 mmHg. There was a dramatic drop in sodium excretion (88–97%). With candesartan and elevated IAP, there was a drop in mean arterial pressure (from 90 to 55 mmHg) and the negative renal effects were very pronounced. Renal function was better preserved during elevated IAP in combination with volume expansion. Conclusions. Capnoperitoneum suppresses renal function, especially in combination with angiotensin II receptor 1 blockade and ACE inhibition. Volume expansion reduces the deleterious effects of PP on renal function during elevated IAP. The results suggest that patients should not be given pharmaceuticals blocking the renin–angiotensin–aldosterone system prior to procedures that may increase IAP. It may be beneficial, however, to reduce angiotensin II tension by volume expansion.</description><identifier>ISSN: 0931-0509</identifier><identifier>ISSN: 1460-2385</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfg362</identifier><identifier>PMID: 14551353</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Angiotensin II Type 1 Receptor Blockers ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Benzimidazoles - pharmacology ; Biological and medical sciences ; candesartan ; Captopril - pharmacology ; Digestive system. Abdomen ; Disease Models, Animal ; Endoscopy ; glomerular filtration rate ; intra-abdominal pressure ; Investigative techniques, diagnostic techniques (general aspects) ; Kidney - drug effects ; Kidney - physiopathology ; Male ; Medical sciences ; oliguria ; pneumoperitoneum ; Pneumoperitoneum, Artificial - adverse effects ; Pressure ; Rats ; Rats, Inbred Strains ; Renin-Angiotensin System - drug effects ; Renin-Angiotensin System - physiology ; Tetrazoles - pharmacology ; volume expansion</subject><ispartof>Nephrology, dialysis, transplantation, 2003-11, Vol.18 (11), p.2269-2277</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-6f98190c7d4fba63c7e844487212f33a30eab4710184c066555ec3f39ed8ecb53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15219733$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14551353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lindström, Pernilla</creatorcontrib><creatorcontrib>Wadström, Jonas</creatorcontrib><creatorcontrib>Ollerstam, Anna</creatorcontrib><creatorcontrib>Johnsson, Cecilia</creatorcontrib><creatorcontrib>Persson, A. Erik G.</creatorcontrib><title>Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol. Dial. Transplant</addtitle><description>Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg by insufflation of CO2 and maintained for 2 h in anaesthetized and mechanically ventilated rats. Rats with normal IAP served as controls. An angiotensin II receptor I antagonist, candesartan, was given as a bolus injection and a 5% volume expansion was achieved by i.v. saline infusion. An angiotensin-converting enzyme (ACE) inhibitor was also given. Renal parameters were the glomerular filtration rate (GFR), urine production, the urinary concentrations of sodium and potassium and the osmolality in the urine. The arterial acid–base balance and blood pressure were also monitored. Results. The GFR deteriorated by 70% during pneumoperitoneum (PP) of 10 mmHg. There was a dramatic drop in sodium excretion (88–97%). With candesartan and elevated IAP, there was a drop in mean arterial pressure (from 90 to 55 mmHg) and the negative renal effects were very pronounced. Renal function was better preserved during elevated IAP in combination with volume expansion. Conclusions. Capnoperitoneum suppresses renal function, especially in combination with angiotensin II receptor 1 blockade and ACE inhibition. Volume expansion reduces the deleterious effects of PP on renal function during elevated IAP. The results suggest that patients should not be given pharmaceuticals blocking the renin–angiotensin–aldosterone system prior to procedures that may increase IAP. It may be beneficial, however, to reduce angiotensin II tension by volume expansion.</description><subject>Angiotensin II Type 1 Receptor Blockers</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Benzimidazoles - pharmacology</subject><subject>Biological and medical sciences</subject><subject>candesartan</subject><subject>Captopril - pharmacology</subject><subject>Digestive system. Abdomen</subject><subject>Disease Models, Animal</subject><subject>Endoscopy</subject><subject>glomerular filtration rate</subject><subject>intra-abdominal pressure</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Kidney - drug effects</subject><subject>Kidney - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>oliguria</subject><subject>pneumoperitoneum</subject><subject>Pneumoperitoneum, Artificial - adverse effects</subject><subject>Pressure</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Renin-Angiotensin System - drug effects</subject><subject>Renin-Angiotensin System - physiology</subject><subject>Tetrazoles - pharmacology</subject><subject>volume expansion</subject><issn>0931-0509</issn><issn>1460-2385</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0M9rFTEQB_BQlPZZe-kfUHLRg7A2v7N71FJbpSCI0tJLmM1O6upu9plkpf733eU9LBnIMPNhDl9CTjl7z1kjz2NXzh_CgzTigGy4MqwSstYvyGZZ8opp1hyRVzn_Yow1wtpDcsSV1lxquSHuMgT0JdMp0D76hJCxW7qSoIK2m8Y-wkC3CXOeE1KIHf07DfOIFB-3EHM_RbpUwpWFOfqyTvpIy0-kCcpr8jLAkPFk_x-TH58uv19cVzdfrz5ffLipvKxtqUxoat4wbzsVWjDSW6yVUrUVXAQpQTKEVlnOeK08M0ZrjV4G2WBXo2-1PCZvd3e3afozYy5u7LPHYYCI05yd1esT9QLf7aBPU84Jg9umfoT0z3Hm1jjdEqfbxbngs_3VuR2xe6b7_BbwZg8gexhCguj7_Oy04I2Vq6t2rs8FH__vIf12xkqr3fXdvftohPhivil3K58AnmqNvA</recordid><startdate>20031101</startdate><enddate>20031101</enddate><creator>Lindström, Pernilla</creator><creator>Wadström, Jonas</creator><creator>Ollerstam, Anna</creator><creator>Johnsson, Cecilia</creator><creator>Persson, A. Erik G.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20031101</creationdate><title>Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat</title><author>Lindström, Pernilla ; Wadström, Jonas ; Ollerstam, Anna ; Johnsson, Cecilia ; Persson, A. Erik G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-6f98190c7d4fba63c7e844487212f33a30eab4710184c066555ec3f39ed8ecb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Angiotensin II Type 1 Receptor Blockers</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Benzimidazoles - pharmacology</topic><topic>Biological and medical sciences</topic><topic>candesartan</topic><topic>Captopril - pharmacology</topic><topic>Digestive system. Abdomen</topic><topic>Disease Models, Animal</topic><topic>Endoscopy</topic><topic>glomerular filtration rate</topic><topic>intra-abdominal pressure</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Kidney - drug effects</topic><topic>Kidney - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>oliguria</topic><topic>pneumoperitoneum</topic><topic>Pneumoperitoneum, Artificial - adverse effects</topic><topic>Pressure</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Renin-Angiotensin System - drug effects</topic><topic>Renin-Angiotensin System - physiology</topic><topic>Tetrazoles - pharmacology</topic><topic>volume expansion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lindström, Pernilla</creatorcontrib><creatorcontrib>Wadström, Jonas</creatorcontrib><creatorcontrib>Ollerstam, Anna</creatorcontrib><creatorcontrib>Johnsson, Cecilia</creatorcontrib><creatorcontrib>Persson, A. Erik G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lindström, Pernilla</au><au>Wadström, Jonas</au><au>Ollerstam, Anna</au><au>Johnsson, Cecilia</au><au>Persson, A. Erik G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><addtitle>Nephrol. Dial. Transplant</addtitle><date>2003-11-01</date><risdate>2003</risdate><volume>18</volume><issue>11</issue><spage>2269</spage><epage>2277</epage><pages>2269-2277</pages><issn>0931-0509</issn><issn>1460-2385</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>Background. The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP. Methods. IAP was elevated to 5 or 10 mmHg by insufflation of CO2 and maintained for 2 h in anaesthetized and mechanically ventilated rats. Rats with normal IAP served as controls. An angiotensin II receptor I antagonist, candesartan, was given as a bolus injection and a 5% volume expansion was achieved by i.v. saline infusion. An angiotensin-converting enzyme (ACE) inhibitor was also given. Renal parameters were the glomerular filtration rate (GFR), urine production, the urinary concentrations of sodium and potassium and the osmolality in the urine. The arterial acid–base balance and blood pressure were also monitored. Results. The GFR deteriorated by 70% during pneumoperitoneum (PP) of 10 mmHg. There was a dramatic drop in sodium excretion (88–97%). With candesartan and elevated IAP, there was a drop in mean arterial pressure (from 90 to 55 mmHg) and the negative renal effects were very pronounced. Renal function was better preserved during elevated IAP in combination with volume expansion. Conclusions. Capnoperitoneum suppresses renal function, especially in combination with angiotensin II receptor 1 blockade and ACE inhibition. Volume expansion reduces the deleterious effects of PP on renal function during elevated IAP. The results suggest that patients should not be given pharmaceuticals blocking the renin–angiotensin–aldosterone system prior to procedures that may increase IAP. It may be beneficial, however, to reduce angiotensin II tension by volume expansion.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>14551353</pmid><doi>10.1093/ndt/gfg362</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0931-0509 |
ispartof | Nephrology, dialysis, transplantation, 2003-11, Vol.18 (11), p.2269-2277 |
issn | 0931-0509 1460-2385 1460-2385 |
language | eng |
recordid | cdi_proquest_miscellaneous_75757528 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Angiotensin II Type 1 Receptor Blockers Angiotensin-Converting Enzyme Inhibitors - pharmacology Animals Benzimidazoles - pharmacology Biological and medical sciences candesartan Captopril - pharmacology Digestive system. Abdomen Disease Models, Animal Endoscopy glomerular filtration rate intra-abdominal pressure Investigative techniques, diagnostic techniques (general aspects) Kidney - drug effects Kidney - physiopathology Male Medical sciences oliguria pneumoperitoneum Pneumoperitoneum, Artificial - adverse effects Pressure Rats Rats, Inbred Strains Renin-Angiotensin System - drug effects Renin-Angiotensin System - physiology Tetrazoles - pharmacology volume expansion |
title | Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T14%3A54%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20increased%20intra-abdominal%20pressure%20and%20volume%20expansion%20on%20renal%20function%20in%20the%20rat&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Lindstro%CC%88m,%20Pernilla&rft.date=2003-11-01&rft.volume=18&rft.issue=11&rft.spage=2269&rft.epage=2277&rft.pages=2269-2277&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfg362&rft_dat=%3Cproquest_cross%3E75757528%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75757528&rft_id=info:pmid/14551353&rfr_iscdi=true |